Laboratory managers seeking more efficient ways to manage R&D data can look to ACD/Labs’ newly released Spectrus Platform 2024. This upgrade helps labs streamline their digital transformation processes, breaking down silos between systems and improving overall data integrity through automated integration and advanced AI tools.
The latest enhancements in Spectrus 2024 address critical bottlenecks in pharmaceutical process development and high throughput experimentation. Tools such as Luminata® and Katalyst D2D® now offer support for accelerated stability studies, helping labs speed up drug shelf life determination while minimizing manual work.
Key benefits for lab managers:
- Increased Efficiency: Automated structure verification reduces manual tasks and speeds up processes.
- Better Data Integrity: Improved integration with third-party software reduces errors and duplication.
- Enhanced AI Capabilities: Supports labs in extracting actionable insights from vast datasets.
- Faster Decision-Making: Enhanced NMR and MS analysis tools for rapid qualitative and quantitative evaluations.
- Streamlined Collaboration: Centralized data management for easier access and sharing between researchers.
With Spectrus Platform 2024, lab managers can achieve greater efficiency, empowering their teams to focus on high-value tasks and deliver results faster.
This article is a summary of a published press release provided by ACD/Labs
